期刊
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
卷 12, 期 4, 页码 1113-1126出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2015.12.365
关键词
Drug delivery; Folate; Nanoparticles; Rheumatoid arthritis; Stealth
资金
- Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/81269/2011]
- European Union [NMP4-LA-2009-228827 NANOFOL]
- FCT [UID/BIO/04469/2013, RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462), UID/BIA/04050/2013]
- Project BioHealth - Biotechnology and Bioengineering approaches to improve health quality - Programa Operacional Regional do Norte (ON.2- O Novo Norte), QREN, FEDER [NORTE-07-0124-FEDER-000027]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/81269/2011] Funding Source: FCT
Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease, affecting almost 1% of the world population. Although the cause of RA remains unknown, the complex interaction between immune mediators (cytokines and effector cells) is responsible for the joint damage that begins at the synovial membrane. Activated macrophages are critical in the pathogenesis of RA and showed specifically express a receptor for the vitamin folic acid (FA), folate receptor beta (FR beta). This particular receptor allows internalization of FA-coupled cargo. In this review we will address the potential of nanoparticles as an effective drug delivery system for therapies that will directly target activated macrophages. Special attention will be given to stealth degree of the nanoparticles as a strategy to avoid clearance by macrophages of the mononuclear phagocytic system (MPS). This review summarizes the application of FA-target nanoparticles as drug delivery systems for RA and proposes prospective future directions. From the Clinical Editor: Rheumatoid arthritis is a debilitating autoimmune disease of the joints which affects many people worldwide. Up till now, there is a lack of optimal therapy against this disease. In this review article, the authors outlined in depth the current mechanism of disease for rheumatoid arthritis and described the latest research in using folic acid-targeted nanoparticles to target synovial macrophages in the fight against rheumatoid arthritis. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据